Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United States of America ex rel. Bernard Lisitza et al v. Par Pharmaceutical Companies, Inc. et al
Case Number:
1:06-cv-06131
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
August 18, 2017
Par Pharmaceutical Beats FCA Prescription-Switch Claims
Par Pharmaceutical Cos. Inc. beat False Claims Act allegations brought by a retired pharmacist, the U.S. and two states, when an Illinois federal judge ruled Thursday that the pharmacist was not the original source for the prescription-switching allegations and that the Medicaid claims were not actually shown to be false.
-
September 12, 2016
Par Pharmaceutical Says Escobar Nixes Gov't FCA Suit
A False Claims Act suit alleging generics maker Par Pharmaceutical Companies Inc. arranged for pharmacists to dispense its own versions of drugs in more expensive forms can't survive new standards set in the U.S. Supreme Court's recent Escobar ruling, the company told an Illinois federal judge Friday.